3rd edition of The IBD congress Today and Tomorrow
Optimal treatment of Crohn’s disease and ulcerative colitis is still a challenge as long as we have no definitive curative treatment. Novel insights in the understanding of the disease and spin-off thereof with regard to novel drugs and improving treatment strategies is developing rapidly. This is the focus of our two-day IBD Today & Tomorrow congress. How to keep pace with the newest developments and implementing them already today or tomorrow.
European Postgraduate Gastro-surgical School at the Academic Medical Center (AMC)
Hall 10 and Auditorium 2000
1 April 2017
Deadline for early registration at reduced fee
Deadline for guaranteed hotel accommodation